IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC)

Arndt Vogel, Oliver Waidmann, Tobias Muller, Gabriele Margareta Siegler, Thorsten Oliver Goetze, Enrico N. De Toni, Maria A. Gonzalez-Carmona, Guido Hausner, Michael Geissler, Ludwig Fischer von Weikersthal, Angelika M. R. Kestler, Fabian Finkelmeier, Matthias Kleiss, Jens U. Marquardt, Andreas Teufel, Jorge Klagges, Regina Eickhoff, Salah-Eddin Al-Batran, Anna Lena Saborowski

Research output: Contribution to journalOriginal Articlepeer-review

4 Citations (Web of Science)
Original languageUndefined/Unknown
JournalJournal of Clinical Oncology
Publication statusPublished - 2023

Cite this